National Cancer Survivors Day 2016:

Host your own Pause for the Cause Coffee Party!

CCSN Webinar - Pharmacare: Caveat Emptor (Let the Buyer Beware)

Register now!

Get involved at your local hospital:

Join a Hospital Patient & Family Advisory Council!

Stay up to date with the latest news and events.

Follow us on Twitter!

Oncology Roundtable:

Establishing a collective patient vision and set of principles for a national pharmacare strategy

Pause for the Cause Coffee Parties:

Support Canada's 1 million cancer survivors!

Latest News


  • 31 May

    Expert Angle Webinar with Dr. Roger Zemp

    On Tuesday, May 31 at 7pm EST, join Dr. Roger Zemp as he presents Amplifying blood biomarkers with ultrasound to help predict the aggressiveness of prostate cancer. Join Dr. Roger Zemp to learn about how: Blood biomarkers are used in…

  • 2 June

    CCSN Webinar - Pharmacare: Caveat Emptor (Let the Buyer Beware)

    Date: Thursday, June 2, 2016 Time: 1:00 PM EDT - 2:00 PM EDT Registration: Click here! Webinar Information Tune in from 1-2pm EDT on Thursday, June 2 for our next webinar titled: “Pharmacare: Caveat Emptor (Let the Buyer Beware).” Oncology…

  • 9 June

    Young Adult Cancer Canada - Survivor Conference

    We opened registration for our 9th Survivor Conference over the weekend, and are already on our way to filling it up! First-time and returning YACCers will join us in our hometown of St. John's, NL between June 9-13 for four…

  • 12 June

    International Symposium on Pediatric Neuro-Oncology

    Abstract Submission is NOW CLOSED The Children’s Hospital Westmead Travelling Fellowship Grant Application deadline has been extended to Friday 1st April 2016. Early bird booking closes: EXTENDED to Tuesday, 5th April 2016 Dear Colleagues and Friends of the Pediatric Neuro-Oncology…

  • 16 June

    Comedy Show about Breast Cancer - Lovely Lady Lump

    Tickets available here!

  • 20 June

    National Pancreatic Cancer Advocacy Day 2016

    MAKE THE IMPOSSIBLE POSSIBLE AT NATIONAL PANCREATIC CANCER ADVOCACY DAY JUNE 20 AND 21 | WASHINGTON, D.C. "Life-changing. That is Advocacy Day. To be surrounded last year by people I had never met but had an instant connection with, while…

Stay informed

Read our most recent eletter


CCSN is looking for volunteer treasurer! Click here to apply

Have you participated in a clinical trial in Canada? Take this survey!

Job Posting: Health Technology Assessment Patient Engagement Navigator

Job Posting: College Chair, Patient and Citizen Engagement

pCODR is recruiting 1 oncologist to be an Expert Review Committee Member. Click here to learn more.

Get involved at your local hospital by joining a Hospital Patient & Family Advisory Council. Click here to find one in your area!

Have you experienced delays waiting for take-home cancer drugs? Have you experienced issues at your pharmacy or outside of the cancer system? Share your story with CanCertainty.

Take part in this study on prostate cancer: click here to find out how.

Join the Toronto Central Local Health Integration Network’s Citizens’ Panel!

Get involved in a research study focusing on your experience with breast cancer – Click here to find out how.

New Pilot Initiative: Increasing Opportunities for Clinician Input and Feedback in CADTH pan-Canadian Oncology Drug Review Process

Would you like to be nominated to sit on cancer and other healthcare boards? Volunteer for CCSN’s A Seat at the Table!

Are you a female between the ages on 30-56 with a BRCA gene mutation? Click here to learn about this research study!

From our blog

Transparent Public Pricing for Biosimilars: pCPA Releases First Principles for SEBs

April 25 2016

Guest Blog By Arvind ManiDirector of Market Access and Policy ResearchPDCI Market AccessThe pan-Canadian Pharmaceutical Alliance (pCPA) recently issued a communiqué outlining their initial perspective on subsequent entry biologics (SEBs)… Read more of Transparent Public Pricing for Biosimilars: pCPA Releases First Principles for SEBs

  • Janssen
  • Eisai
  • Acart Communications
  • Amgen Canada
  • Brazeau Seller LLP
  • Merck Canada
  • Astellas Oncology
  • Novartis
  • Boehringer Ingelheim
  • EnergiPR
  • Rx&D
  • CannTrust
  • Eli Lilly Oncology
  • Phirelight